BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20003995)

  • 1. A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.
    Kraus MH; Parrish NF; Shaw KS; Decker JM; Keele BF; Salazar-Gonzalez JF; Grayson T; McPherson DT; Ping LH; Anderson JA; Swanstrom R; Williamson C; Shaw GM; Hahn BH
    Virology; 2010 Feb; 397(2):346-57. PubMed ID: 20003995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1.
    Langer SM; Hopfensperger K; Iyer SS; Kreider EF; Learn GH; Lee LH; Hahn BH; Sauter D
    PLoS One; 2015; 10(11):e0142118. PubMed ID: 26554585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.
    Lucas TM; Lyddon TD; Cannon PM; Johnson MC
    J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Arrigo SJ; Chen IS
    Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.
    Lucas TM; Janaka SK; Stephens EB; Johnson MC
    PLoS One; 2012; 7(12):e51741. PubMed ID: 23284757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype.
    Dimonte S; Babakir-Mina M; Aquaro S; Perno CF
    Virol Sin; 2012 Dec; 27(6):360-68. PubMed ID: 23271577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.
    Schubert U; Bour S; Willey RL; Strebel K
    J Virol; 1999 Feb; 73(2):887-96. PubMed ID: 9882289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that Vpu modulates HIV-1 Gag-envelope interaction towards envelope incorporation and infectivity in a cell type dependent manner.
    Gautam A; Bhattacharya J
    PLoS One; 2013; 8(4):e61388. PubMed ID: 23613843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs.
    Anderson JL; Johnson AT; Howard JL; Purcell DF
    J Virol; 2007 May; 81(9):4664-76. PubMed ID: 17329338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm.
    Tranell A; Tingsborg S; Fenyö EM; Schwartz S
    Virus Res; 2011 Apr; 157(1):82-91. PubMed ID: 21345357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
    Bour S; Strebel K
    J Virol; 1996 Dec; 70(12):8285-300. PubMed ID: 8970948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.
    Schwartz S; Felber BK; Fenyö EM; Pavlakis GN
    J Virol; 1990 Nov; 64(11):5448-56. PubMed ID: 2214021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate.
    Hill MS; Ruiz A; Pacyniak E; Pinson DM; Culley N; Yen B; Wong SW; Stephens EB
    Virology; 2008 Feb; 371(1):86-97. PubMed ID: 17950774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
    Van Damme N; Guatelli J
    Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
    Vincent MJ; Raja NU; Jabbar MA
    J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.
    Stephens EB; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Nothnick W; Wong SW; Gunderson R; Berman NE; Singh DK
    Virology; 2002 Feb; 293(2):252-61. PubMed ID: 11886245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
    Bour S; Schubert U; Peden K; Strebel K
    J Virol; 1996 Feb; 70(2):820-9. PubMed ID: 8551620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.